Ardelyx Inc (ARDX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: ARDX Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-04-17 2024-04-15 PS Planned sale

RAAB MICHAEL

President & CEO

Executive Director
1,000 -0.6%
7.06
100,000 USD 		1,000 -0.6% 7.06 100,000 USD
2024-04-02 2024-04-01 PS Planned sale

RAAB MICHAEL

President & CEO

Executive Director
1,518 -0.1%
7.31
11,097 USD 		1,518 -0.1% 7.31 11,097 USD
2024-03-22 2024-03-20 PS Planned sale

GRAMMER ELIZABETH A

See Remarks

Officer
86,000 -21.6%
7.73
664,978 USD 		86,000 -21.6% 7.73 664,978 USD
2024-02-28 2024-02-26 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
5,183 -2.9%
9.20
47,684 USD 		5,183 -2.9% 9.20 47,684 USD
2024-02-22 2024-02-20 S Sale

Felsch Robert Ora

See Remarks

Officer
2,352 -1.3%
8.75
20,571 USD 		2,352 -1.3% 8.75 20,571 USD
2024-02-22 2024-02-20 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
2,294 -1.3%
8.75
20,064 USD 		2,294 -1.3% 8.75 20,064 USD
2024-02-22 2024-02-20 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
5,017 -1.3%
8.75
43,880 USD 		5,017 -1.3% 8.75 43,880 USD
2024-02-22 2024-02-20 S Sale

GRAMMER ELIZABETH A

See Remarks

Officer
4,432 -1.1%
8.75
38,764 USD 		4,432 -1.1% 8.75 38,764 USD
2024-02-22 2024-02-20 S Sale

Renz Justin A

Chief Financial Officer

Officer
5,341 -1.7%
8.75
46,714 USD 		5,341 -1.7% 8.75 46,714 USD
2024-02-22 2024-02-20 S Sale

Blanks Robert

See Remarks

Officer
5,017 -1.3%
8.75
43,880 USD 		5,017 -1.3% 8.75 43,880 USD
2024-02-22 2024-02-20 S Sale

Williams Laura A

Chief Medical Officer

Officer
4,803 -1.2%
8.75
42,008 USD 		4,803 -1.2% 8.75 42,008 USD
2024-02-22 2024-02-20 S Sale

Rodriguez Susan

Chief Commercial Officer

Officer
6,928 -1.5%
8.75
60,594 USD 		6,928 -1.5% 8.75 60,594 USD
2024-02-22 2024-02-20 S Sale

RAAB MICHAEL

President & CEO

Executive Director
22,917 -1.7%
8.75
200,439 USD 		22,917 -1.7% 8.75 200,439 USD
2024-02-09 2024-02-08 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
15,344 -3.8%
9.18
140,846 USD 		15,344 -3.8% 9.18 140,846 USD
2024-01-10 2024-01-08 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
30,000 -9.5%
6.64
199,200 USD 		30,000 -9.5% 6.64 199,200 USD
2023-12-28 2023-12-26 PS Planned sale

Renz Justin A

Chief Financial Officer

Officer
225,000 -55.2%
6.36
1,430,123 USD 		225,000 -55.2% 6.36 1,430,123 USD
2023-12-20 2023-12-18 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
5,675 -1.8%
6.07
34,447 USD 		5,675 -1.8% 6.07 34,447 USD
2023-12-15 2023-12-14 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
7,000 -2.1%
5.55
38,850 USD 		7,000 -2.1% 5.55 38,850 USD
2023-12-13 2023-12-11 PS Planned sale

GRAMMER ELIZABETH A

See Remarks

Officer
50,000 -15.4%
5.08
253,925 USD 		50,000 -15.4% 5.08 253,925 USD
2023-12-08 2023-12-08 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
20,000 -5.7%
5.27
105,476 USD 		20,000 -5.7% 5.27 105,476 USD
2023-12-06 2023-12-05 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
10,272 -2.9%
5.00
51,360 USD 		10,272 -2.9% 5.00 51,360 USD
2023-12-01 2023-11-30 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
3,000 -0.8%
4.50
13,500 USD 		3,000 -0.8% 4.50 13,500 USD
2023-11-22 2023-11-20 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
932 -0.8%
4.36
4,066 USD 		932 -0.8% 4.36 4,066 USD
2023-11-22 2023-11-20 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
2,835 -0.8%
4.36
12,367 USD 		2,835 -0.8% 4.36 12,367 USD
2023-11-22 2023-11-20 PS Planned sale

Williams Laura A

Chief Medical Officer

Officer
2,581 -1.0%
4.36
11,259 USD 		2,581 -1.0% 4.36 11,259 USD
2023-11-22 2023-11-20 PS Planned sale

Renz Justin A

Chief Financial Officer

Officer
2,873 -0.9%
4.36
12,533 USD 		2,873 -0.9% 4.36 12,533 USD
2023-11-22 2023-11-20 S Sale

Blanks Robert

See Remarks

Officer
2,835 -1.1%
4.36
12,367 USD 		2,835 -1.1% 4.36 12,367 USD
2023-11-22 2023-11-20 PS Planned sale

Rodriguez Susan

Chief Commercial Officer

Officer
4,714 -1.3%
4.36
20,563 USD 		4,714 -1.3% 4.36 20,563 USD
2023-11-22 2023-11-20 PS Planned sale

RAAB MICHAEL

President & CEO

Executive Director
11,368 -1.3%
4.36
49,589 USD 		11,368 -1.3% 4.36 49,589 USD
2023-11-22 2023-11-20 S Sale

GRAMMER ELIZABETH A

See Remarks

Officer
2,384 -0.7%
4.36
10,399 USD 		2,384 -0.7% 4.36 10,399 USD
2023-11-22 2023-11-20 PS Planned sale

Felsch Robert Ora

See Remarks

Officer
1,044 -0.9%
4.36
4,554 USD 		1,044 -0.9% 4.36 4,554 USD
2023-11-17 2023-11-15 S Sale

Williams Laura A

Chief Medical Officer

Officer
25,000 -8.6%
4.00
99,998 USD 		25,000 -8.6% 4.00 99,998 USD
2023-10-12 2023-10-10 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
1,644 -0.4%
4.00
6,576 USD 		1,644 -0.4% 4.00 6,576 USD
2023-09-12 2023-09-08 PS Planned sale

Rosenbaum David P.

Chief Development Officer

Officer
2,897 -0.8%
4.55
13,181 USD 		2,897 -0.8% 4.55 13,181 USD
2023-08-23 2023-08-21 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
937 -0.8%
3.55
3,328 USD 		937 -0.8% 3.55 3,328 USD
2023-08-23 2023-08-21 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
2,846 -0.8%
3.55
10,108 USD 		2,846 -0.8% 3.55 10,108 USD
2023-08-23 2023-08-21 S Sale

Blanks Robert

See Remarks

Officer
2,846 -1.1%
3.55
10,108 USD 		2,846 -1.1% 3.55 10,108 USD
2023-08-23 2023-08-21 S Sale

Felsch Robert Ora

See Remarks

Officer
1,048 -0.9%
3.55
3,722 USD 		1,048 -0.9% 3.55 3,722 USD
2023-08-23 2023-08-21 S Sale

Renz Justin A

Chief Financial Officer

Officer
2,884 -0.9%
3.55
10,243 USD 		2,884 -0.9% 3.55 10,243 USD
2023-08-23 2023-08-21 S Sale

GRAMMER ELIZABETH A

See Remarks

Officer
2,392 -0.7%
3.55
8,496 USD 		2,392 -0.7% 3.55 8,496 USD
2023-08-23 2023-08-21 S Sale

RAAB MICHAEL

President & CEO

Executive Director
11,419 -1.3%
3.55
40,558 USD 		11,419 -1.3% 3.55 40,558 USD
2023-08-23 2023-08-21 S Sale

Rodriguez Susan

Chief Commercial Officer

Officer
4,733 -1.3%
3.55
16,811 USD 		4,733 -1.3% 3.55 16,811 USD
2023-08-23 2023-08-21 S Sale

Williams Laura A

Chief Medical Officer

Officer
2,591 -0.9%
3.55
9,203 USD 		2,591 -0.9% 3.55 9,203 USD
2023-06-29 2023-06-27 S Sale

Williams Laura A

Chief Medical Officer

Officer
25,000 -7.8%
3.35
83,633 USD 		25,000 -7.8% 3.35 83,633 USD
2023-06-27 2023-06-23 PS Planned sale

Blanks Robert

See Remarks

Officer
33,333 -11.1%
3.63
121,042 USD 		33,333 -11.1% 3.63 121,042 USD
2023-05-25 2023-05-23 PS Planned sale

Renz Justin A

Chief Financial Officer

Officer
2,873 -0.8%
3.65
10,496 USD 		2,873 -0.8% 3.65 10,496 USD
2023-05-25 2023-05-23 PS Planned sale

Rodriguez Susan

Chief Commercial Officer

Officer
4,711 -1.3%
3.65
17,210 USD 		4,711 -1.3% 3.65 17,210 USD
2023-05-25 2023-05-23 PS Planned sale

Williams Laura A

Chief Medical Officer

Officer
2,583 -0.8%
3.65
9,436 USD 		2,583 -0.8% 3.65 9,436 USD
2023-05-25 2023-05-23 S Sale

Blanks Robert

See Remarks

Officer
2,835 -1.1%
3.65
10,357 USD 		2,835 -1.1% 3.65 10,357 USD
2023-05-25 2023-05-23 PS Planned sale

Felsch Robert Ora

See Remarks

Officer
1,046 -0.9%
3.65
3,821 USD 		1,046 -0.9% 3.65 3,821 USD
2023-05-25 2023-05-23 PS Planned sale

RAAB MICHAEL

President & CEO

Executive Director
11,357 -1.3%
3.65
41,489 USD 		11,357 -1.3% 3.65 41,489 USD
2023-05-25 2023-05-23 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
934 -0.8%
3.65
3,412 USD 		934 -0.8% 3.65 3,412 USD
2023-05-25 2023-05-23 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
2,835 -0.8%
3.65
10,357 USD 		2,835 -0.8% 3.65 10,357 USD
2023-05-25 2023-05-23 PS Planned sale

GRAMMER ELIZABETH A

See Remarks

Officer
2,384 -0.7%
3.65
8,709 USD 		2,384 -0.7% 3.65 8,709 USD
2023-03-02 2023-02-21 S Sale

Rodriguez Susan

Chief Commercial Officer

Officer
5,586 -1.5%
3.00
16,764 USD 		5,586 -1.5% 3.00 16,764 USD
2023-02-24 2023-02-21 S Sale

RAAB MICHAEL

President & CEO

Executive Director
13,449 -1.5%
3.00
40,360 USD 		13,449 -1.5% 3.00 40,360 USD
2023-02-24 2023-02-21 S Sale

Felsch Robert Ora

See Remarks

Officer
3,214 -2.7%
3.00
9,645 USD 		3,214 -2.7% 3.00 9,645 USD
2023-02-24 2023-02-21 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
1,114 -1.0%
3.00
3,343 USD 		1,114 -1.0% 3.00 3,343 USD
2023-02-24 2023-02-21 S Sale

Rosenbaum David P.

Chief Development Officer

Officer
3,394 -0.9%
3.00
10,185 USD 		3,394 -0.9% 3.00 10,185 USD
2023-02-24 2023-02-21 S Sale

Renz Justin A

Chief Financial Officer

Officer
3,439 -1.0%
3.00
10,320 USD 		3,439 -1.0% 3.00 10,320 USD
2023-02-24 2023-02-21 S Sale

Blanks Robert

See Remarks

Officer
3,394 -1.2%
3.00
10,185 USD 		3,394 -1.2% 3.00 10,185 USD
2023-02-24 2023-02-21 S Sale

Williams Laura A

Chief Medical Officer

Officer
3,187 -1.0%
3.00
9,564 USD 		3,187 -1.0% 3.00 9,564 USD
2023-02-24 2023-02-21 S Sale

GRAMMER ELIZABETH A

See Remarks

Officer
2,914 -0.9%
3.00
8,745 USD 		2,914 -0.9% 3.00 8,745 USD
2022-11-23 2022-11-22 S Sale

Williams Laura A

Chief Medical Officer

Officer
1,193 -0.5%
1.95
2,326 USD 		1,193 -0.5% 1.95 2,326 USD
2022-11-23 2022-11-22 S Sale

Williams Laura A

Chief Medical Officer

Officer
33 -0.0%
1.95
64 USD 		33 -0.0% 1.95 64 USD
2022-11-23 2022-11-22 S Sale

Williams Laura A

Chief Medical Officer

Officer
15 -0.0%
1.94
29 USD 		15 -0.0% 1.94 29 USD
2022-11-23 2022-11-22 S Sale

Rodriguez Susan

Chief Commercial Officer

Officer
3,303 -1.2%
1.95
6,439 USD 		3,303 -1.2% 1.95 6,439 USD
2022-11-23 2022-11-22 S Sale

Rodriguez Susan

Chief Commercial Officer

Officer
22 -0.0%
1.95
43 USD 		22 -0.0% 1.95 43 USD
2022-11-23 2022-11-22 S Sale

Rodriguez Susan

Chief Commercial Officer

Officer
131 -0.0%
1.94
254 USD 		131 -0.0% 1.94 254 USD
2022-11-23 2022-11-22 S Sale

GRAMMER ELIZABETH A

See Remarks

Officer
1,193 -0.5%
1.95
2,326 USD 		1,193 -0.5% 1.95 2,326 USD
2022-11-23 2022-11-22 S Sale

GRAMMER ELIZABETH A

See Remarks

Officer
20 -0.0%
1.95
39 USD 		20 -0.0% 1.95 39 USD
2022-11-23 2022-11-22 S Sale

GRAMMER ELIZABETH A

See Remarks

Officer
29 -0.0%
1.94
56 USD 		29 -0.0% 1.94 56 USD
2022-11-23 2022-11-22 S Sale

Renz Justin A

Chief Financial Officer

Officer
1,443 -0.5%
1.95
2,813 USD 		1,443 -0.5% 1.95 2,813 USD
2022-11-23 2022-11-22 S Sale

Renz Justin A

Chief Financial Officer

Officer
61 -0.0%
1.94
118 USD 		61 -0.0% 1.94 118 USD
2022-11-23 2022-11-22 S Sale

Blanks Robert

See Remarks

Officer
1,405 -0.7%
1.95
2,739 USD 		1,405 -0.7% 1.95 2,739 USD